Riskpilot← Back to searchSign inGet full accessNORICHICK AS
ASActiveOrg 917246211Depotgata 22, 2000 LillestrømForskning og utviklingsarbeid innen bioteknologi · NACE 72110Est. 20161 employees
Revenue 2020
NOK 692K
-22% vs 2019
EBITDA margin
-85.7%
+25% vs 2019
Equity ratio
11.4%
Financial strength
Net profit 2020
NOK -1,2M
+12% vs 2019
| Revenue | NOK 692K | -22% |
| EBITDA | NOK -592K | +25% |
| Net profit | NOK -1,2M | +12% |
| Total assets | NOK 4,2M | -21% |
| Equity | NOK 476K | +111% |
| Employees | 1 | — |
Legal name
NORICHICK AS
Org number
917246211
Legal form
Aksjeselskap
NACE code
72110 · Forskning og utviklingsarbeid innen bioteknologi
Founded
1. juni 2016
Share capital
NOK 19 896 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Å utvikle ingredienser, produkter, teknologi og tjenester knyttet til igy immunglobulin y) som del av funksjonell ernæring og/eller passiv immunisering, innen markedet husdyrproduksjon og spesielt innen produksjon av fjørfe og det som naturlig hører under dette.
Address
Depotgata 22, 2000 Lillestrøm
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 335 | 0 | 0 | 885 | 692 |
| Staff expenses | −421 | −595 | −571 | −839 | −683 |
| EBITDA | −1 155 | −1 929 | −1 288 | −789 | −592 |
| Depreciation & amort. | −0 | −0 | −633 | −634 | −636 |
| EBIT | −1 155 | −1 929 | −1 921 | −1 423 | −1 228 |
| Net financials | 1 | 3 | 2 | 4 | −16 |
| Profit before tax | −1 154 | −1 926 | −1 918 | −1 419 | −1 244 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 154 | −1 926 | −1 918 | −1 419 | −1 244 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 1 120 | 5 409 | 6 427 | 5 278 | 4 190 |
| Equity | 862 | −1 064 | −2 983 | −4 402 | 476 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 258 | 6 473 | 9 410 | 9 679 | 3 713 |
| Total debt | 258 | 6 473 | 9 410 | 9 679 | 3 713 |
EBITDA margin
-85.7%
This company
15.8%
Market median
-642% vs market
20162020
Equity ratio
11.4%
This company
38.2%
Market median
-70% vs market
20162020
Return on equity
-261.2%
This company
18.4%
Market median
-1520% vs market
20162020
Net profit margin
-179.9%
This company
8.1%
Market median
-2321% vs market
20162020
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20162020
Debt / equity
7.80×
This company
0.62×
Market median
-1158% vs market
20162020
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-02-26 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HO Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Chairman | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORICHICK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hallgeir Olsen | Chief Executive Officer | 0 companies |
| Ralf Günter Onken | Board of Directors | 0 companies |
| Knut Kvitvang Røflo | Board of Directors | 0 companies |
| Per Olav Skjervold | Chairman | 0 companies |
| Hanne Christine Øverli | Board of Directors | 0 companies |
| Trude Ulven | Deputy Chairman | 0 companies |